Switch Maintenance Strategy for Metastatic Bladder Cancer

Switch Maintenance Strategy for Metastatic Bladder Cancer

Advanced/Metastatic Urothelial Carcinoma: Understanding Novel Immunotherapy Maintenance StrategiesПодробнее

Advanced/Metastatic Urothelial Carcinoma: Understanding Novel Immunotherapy Maintenance Strategies

Metastatic Bladder Cancer: Progression After MaintenanceПодробнее

Metastatic Bladder Cancer: Progression After Maintenance

Dr. Benjamin Miron on Treatment Patterns and Outcomes Among Patients with Metastatic Bladder CancerПодробнее

Dr. Benjamin Miron on Treatment Patterns and Outcomes Among Patients with Metastatic Bladder Cancer

EV-301 Trial: Treatment for Metastatic Bladder Cancer | Russell Pachynski, MD | ASCO22 UpdatesПодробнее

EV-301 Trial: Treatment for Metastatic Bladder Cancer | Russell Pachynski, MD | ASCO22 Updates

Maintenance Therapy for Metastatic Urothelial CancerПодробнее

Maintenance Therapy for Metastatic Urothelial Cancer

Drs. Kamat, Galsky, & Baack talk the latest in #BladderCancer from #AUA22Подробнее

Drs. Kamat, Galsky, & Baack talk the latest in #BladderCancer from #AUA22

Phase II Trial Considers the Benefit of Switch Maintenance in Urothelial CancerПодробнее

Phase II Trial Considers the Benefit of Switch Maintenance in Urothelial Cancer

Advanced/Metastatic Urothelial Carcinoma: Understanding Novel Immunotherapy Maintenance StrategiesПодробнее

Advanced/Metastatic Urothelial Carcinoma: Understanding Novel Immunotherapy Maintenance Strategies

Changing the Standard of Care in Metastatic Bladder CancerПодробнее

Changing the Standard of Care in Metastatic Bladder Cancer

New emerging treatment options and targeted therapies for bladder cancerПодробнее

New emerging treatment options and targeted therapies for bladder cancer

Increased Survival Outcomes with Switch Maintenance in mUCПодробнее

Increased Survival Outcomes with Switch Maintenance in mUC

JAVELIN Bladder 100 trial: Biomarkers for maintenance avelumab in metastatic urothelial cancerПодробнее

JAVELIN Bladder 100 trial: Biomarkers for maintenance avelumab in metastatic urothelial cancer

Therapeutic Selection, Safety, and Sequencing Along the Bladder Cancer Disease ContinuumПодробнее

Therapeutic Selection, Safety, and Sequencing Along the Bladder Cancer Disease Continuum

JAVELIN BLADDER 100: 1L urothelial cancer updatesПодробнее

JAVELIN BLADDER 100: 1L urothelial cancer updates

Fresh Perspectives on Moving Toward Personalized Care for Bladder CancerПодробнее

Fresh Perspectives on Moving Toward Personalized Care for Bladder Cancer

Optimizing the Management of Metastatic Urothelial Bladder CancerПодробнее

Optimizing the Management of Metastatic Urothelial Bladder Cancer

Maintenance pembrolizumab vs placebo for metastatic urothelial cancerПодробнее

Maintenance pembrolizumab vs placebo for metastatic urothelial cancer

Optimal treatment strategies for patients with metastatic urothelial carcinomaПодробнее

Optimal treatment strategies for patients with metastatic urothelial carcinoma

Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder CancerПодробнее

Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer